GeneNovate Investors' Day - Unlocking the Potential of Gene- and Cell-based Innovations

Save calendar entry
Akademie der Künste

Pariser Platz 4

10117 Berlin

Gene and cell-based therapies (GCT) are one of the most important future topics for biomedical research and the clinical care of patients. The development of these therapies based on excellent research in Germany is driving scientists from academia and industry equally. At GeneNovate Investors' Day, we bring together ambitious start-ups with investors, industry representatives, scientists, patient representatives and experts from politics and regulation. Let's shape the future of medicine together!

 

The importance of gene and cell therapies as well as tissue therapeutics (Advanced Therapy Medicinal Products) is steadily increasing worldwide. In particular, patients with rare diseases - at least affecting 4 million people in Germany - and otherwise untreatable cancer patients can benefit from treatment in the long term. Technological advances, such as the expansion of the use of artificial intelligence, are further dynamizing the field.

Fifteen gene therapies and two cell therapies are currently approved in Europe (as of June 2024). The number of clinical trials worldwide is constantly increasing. Groundbreaking developments are on the horizon for this innovative business field, with sales of up to EUR 27.9 billion expected by 2026. The German government has also recognized the potential of these innovative therapies. In a National Strategy for Gene and Cell-Based Therapies, concrete measures have been defined to improve the framework conditions, e.g. in research and development, regulation or manufacturing practice.  Bringing together different stakeholders is a a key pillar of the strategy. It facilitates the dialogue across disciplinary, sectoral, regional and national boundaries and thus accelerates translation.

This is where the GeneNovate Investors' Day comes in: without smart investments and relevant expert mentoring, no new therapies! GeneNovate Investors' Day is a networking event for scientific, translationally oriented project teams, (international) start-ups, investors and experts from science, industry and politics. Discover with us the latest developments in the field of gene and cell therapies and promising investment opportunities.  Find out more in exciting panels on key topics such as the particular features of the value chain, investment specifics or international best practices. In the heart of Berlin, we create the right atmosphere for personal exchange!

More information: GeneNovate Investors' Day - BIH at Charité (bihealth.org)

If you are interested in participating, have any questions or comments, please contact: genenovate-investors-day@bih-charite.de

 

 

Back